Aberrations in carbohydrate metabolism in patients with diagnosed acromegaly, hospitalized in the Endocrinology and Diabetology Department of Collegium Medicum University of Nicolaus Copernicus in Bydgoszcz in the years 2001-2009

Endokrynologia Polska

Volumn 61, Issue 3, 2010, Pages 260-263

  Gierach, Marcin ^a   Gierach, Joanna ^a   Pujanek, Małgorzata ^a   Skowrońska, Agnieszka ^a   Rutkowska, Emilia ^a   Junik, Roman ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Acromegaly; Diabetes; ICT; IFG

Indexed keywords

GROWTH HORMONE;

ACROMEGALY; ADULT; AGED; ARTICLE; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; UNIVERSITY HOSPITAL;

ACROMEGALY; AGE DISTRIBUTION; AGING; CARBOHYDRATE METABOLISM; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; POLAND; SEX DISTRIBUTION;

EID: 77955613369     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Coculescu M, Niculescu D, Lichiardopol R et al. Insulin resistance and insulin secretion in non-diabetic acromegalic patients. Exp Clin Endocrinol Diabetes 2007; 115: 308-316.
2. Milaszewska K, Krȩtowski A. Zaburzenia gospodarki wȩglowodanowej w akromegalii. Przegla̧d Kardiodiabetologiczny 2009; 4: 90-93.
3. Grzesiuk W, Szydlarska D, Jóźwik K. Insulinoopornoś ć w endokrynopatiach. Endokrynol., Otył. Zab. Przem. Mat. 2008; 5: 38-44.
4. Resmini E, Minuto F, Colao A et al. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities. Acta Diabetol 2009; 46: 85-95.
5. Colao A, Ferone D, Marzullo P et al. Systemic complication of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 2004; 25: 102-152.
6. Kreze A, Kreze-Spirova E, Mikulecky M. Risk factor for glucose intolerance in active acromegaly. Braz J Med Biol Res 2001; 34: 1429-1433. (Pubitemid 34036845)
7. Szelachowska M, Górska M, Zonenberg A. Insulinoopornoś ć w wybranych endokrynopatiach. In: Kinalska I. (ed.). Patofizjologia i nastȩpstwa kliniczne insulinooporności. Wydawnictwo Kliniki Endokrynologii, Diabetologii i Chorób Wewnȩtrznych. W ramach działalności Polskiego Towarzystwa Kardiodiabetologicznego, Białystok 2005: 239-249.
8. Ezzat S, Forster MJ, Berchtold P et al. Acromegaly: clinical and biochemical features in 500 patients. Medicine 1994; 73: 233-240. (Pubitemid 24317670)
9. Stelmachowska-Banaś M, Zdunowski P, Zgliczyński W. Abnormalities in glucose homeostasis in acromegaly. Does the prevalence of glucose intolerance depends on the level of activity of the disease and the duration of the symptoms? Endokrynol Pol 2009; 60: 20-24.
10. Szybiński Z. Polskie wieloośrodkowe badanie nad epidemiologia̧ cukrzycy (PWBEC 1998-2000). Pol Arch Med Wewn 2001; 106: 751.
11. Bierin H, Knapie G, Gerl H et al. Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 2000; 27: 27-31.
12. Katz JR, Edwards R, Khan M et al. Acromegaly presenting with diabetic ketoacidosis. Postgrad Med J 1996; 72: 682-683.